1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Original Article
You have full text access to this OnlineOpen article
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection
Article first published online: 30 DEC 2003
DOI: 10.1053/jhep.2001.24371
Copyright © 2001 American Association for the Study of Liver Diseases
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
Additional Information
How to Cite
Bassett, S. E., Guerra, B., Brasky, K., Miskovsky, E., Houghton, M., Klimpel, G. R. and Lanford, R. E. (2001), Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology, 33: 1479–1487. doi: 10.1053/jhep.2001.24371
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 27 FEB 2001
- Manuscript Received: 20 NOV 2000
Funded by
- National Institutes of Health. Grant Numbers: T32 AI07536, U19 AI40035, P51 RR13986
- Abstract
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Hepatitis C virus vaccines in the era of new direct-acting antivirals, Expert Review of Gastroenterology & Hepatology, 2013, 7, 2, 171
- 2, , , , , , , , , Hepatitis C Virus-Specific Cell-Mediated Immune Responses in Children Born to Mothers Infected with Hepatitis C Virus, The Journal of Pediatrics, 2013, 162, 1, 148
- 3, Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease, Gastroenterology, 2012, 142, 6, 1279
- 4, , , , , , , , , Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine, The Lancet Infectious Diseases, 2012, 12, 5, 408
- 5, , , , , , , , Hepatitis C Virus NS3/NS4A DNA Vaccine Induces Multiepitope T Cell Responses in Rhesus Macaques Mimicking Human Immune Responses, Molecular Therapy, 2012, 20, 3, 669
- 6, , , , , , , , , , , , Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection, Hepatology, 2012, 55, 4Direct Link:
- 7, , Hepatitis C Virus-Mediated Modulation of Cellular Immunity, Archivum Immunologiae et Therapiae Experimentalis, 2012, 60, 5, 315
- 8, , , , , , , , , , , The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study Design, Journal of Infectious Diseases, 2012, 205, 9, 1342
- 9, , , Very Low Viral Load (VLVL) Relapse Following Treatment of Naïve Patients with Chronic Hepatitis C, Digestive Diseases and Sciences, 2012, 57, 1, 243
- 10, , , , , , , , Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes, Virology Journal, 2011, 8, 1, 506
- 11, , , Vaccination for hepatitis C virus: closing in on an evasive target, Expert Review of Vaccines, 2011, 10, 5, 659
- 12, , , , Analyses of amino acid sequences in hypervariable region-1 of hepatitis C virus (HCV) in sera from chimpanzees infected three times with the same HCV strain, Journal of Medical Primatology, 2010, 39, 1Direct Link:
- 13, Chimpanzees in hepatitis C virus research: 1998–2007, Journal of Medical Primatology, 2010, 39, 1Direct Link:
- 14, , , Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins, Gastroenterology, 2010, 139, 3, 965
- 15, , , , , , , , Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection, Gastroenterology, 2010, 138, 1, 315
- 16
- 17, 2010,
- 18, , , , Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy, Epidemiology and Infection, 2009, 137, 02, 241
- 19, , , , , Development of hepatitis C virus vaccines: challenges and progress, Expert Review of Vaccines, 2009, 8, 3, 333
- 20, , , , , , , , Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam, Journal of Hepatology, 2009, 51, 4, 667
- 21, , , HCV reinfection studies and the door to vaccine development, Journal of Hepatology, 2009, 51, 4, 628
- 22, Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence, Journal of Clinical Investigation, 2009, 119, 7, 1745
- 23, , , , , , , , , , T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation, Vaccine, 2009, 27, 19, 2594
- 24, The long and winding road leading to the identification of the hepatitis C virus, Journal of Hepatology, 2009, 51, 5, 939
- 25, , , , , , , , , A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus, Drug and Alcohol Dependence, 2008, 93, 1-2, 148
- 26, , , , Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine, Biological Chemistry, 2008, 389, 5
- 27, , , , , , , , , Anticorps neutralisants dirigés contre le virus de l’hépatite C, Gastroentérologie Clinique et Biologique, 2008, 32, 5, 491
- 28, , , , Hepatitis C vaccine: supply and demand, The Lancet Infectious Diseases, 2008, 8, 6, 379
- 29, , , , , , , , Hepatitis C Virus (HCV)–Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection, The Journal of Infectious Diseases, 2008, 198, 12, 1749
- 30, , , , Hepatitis C Virus Entry and Neutralization, Clinics in Liver Disease, 2008, 12, 3, 693
- 31, , , Host neutralizing responses and pathogenesis of hepatitis C virus infection, Hepatology, 2008, 48, 1Direct Link:
- 32, , , , Immune suppression leading to hepatitis C virus re-emergence after sustained virological response, Journal of Medical Virology, 2008, 80, 10Direct Link:
- You have free access to this content33, , , , Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived, Journal of Medical Virology, 2008, 80, 1Direct Link:
- 34
- 35, , , , , Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine, Vaccine, 2008, 26, 49, 6225
- 36, , , The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure, Journal of Hepatology, 2008, 49, 3, 305
- 37, , , , , , , Development of a heterologous, multigenotype vaccine against hepatitis C virus infection, European Journal of Clinical Investigation, 2007, 37, 5Direct Link:
- 38, , , , , , , , , , , , , Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies, Vaccine, 2007, 25, 45, 7773
- 39, , , Hepatitis C Virus Infection—Pathobiology and Implications for New Therapeutic Options, Digestive Diseases and Sciences, 2007, 52, 4, 857
- 40, , , , , , , , , , Hepatitis C virus quasispecies in HIV-infected women: Role of injecting drug use and highly active antiretroviral therapy (HAART), Hepatology, 2007, 46, 2Direct Link:
- 41, , , , , , , Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection, Immunology and Cell Biology, 2007, 85, 1, 24
- 42, , , , , , , , Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus, Journal of Viral Hepatitis, 2007, 14, 11Direct Link:
- 43, , , , , , , , , Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees, Proceedings of the National Academy of Sciences, 2007, 104, 20, 8427
- 44, , , Respuesta inmunitaria celular adaptativa frente a la infección por el virus de la hepatitis C, Medicina Clínica, 2007, 129, 12, 469
- 45, , , , , , , , , , , , , , , , A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, 2006, 12, 2, 190
- 46, , , , , , , , , , , Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infection, Journal of Hepatology, 2006, 44, 3, 475
- 47, , , , , , , , CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus, Hepatology, 2006, 44, 3Direct Link:
- 48, , , , , , Effective Induction of Type 1 Cytotoxic T Cell Responses in Mice with DNA Vaccine Encoding Two Hepatitis C Virus Cytotoxic T Lymphocyte Epitopes, Viral Immunology, 2006, 19, 4, 702
- 49, , HCV Immunopathogenesis: Virus-Induced Strategies against Host Immunity, Clinics in Liver Disease, 2006, 10, 4, 753
- 50, , Hepatitis C vaccines: Inducing and challenging memory T cells, Hepatology, 2006, 43, 6Direct Link:
- 51, , , , , , Hepatitis C virus reinfection in injection drug users, Hepatology, 2006, 44, 5Direct Link:
- 52
- 53, , , Immunantwort bei der Hepatitis-B- und -C-Virusinfektion, Der Gastroenterologe, 2006, 1, 2, 109
- 54, , IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology: Mechanisms of Disease, 2006, 1, 1, 23
- 55, , , , , , , , , Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse, Vaccine, 2006, 24, 24, 5140
- 56, , , , , , , , , , , , Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection, Journal of Clinical Virology, 2006, 36, 1, 24
- 57, , , , Protective immunity against hepatitis C virus infection, Immunology and Cell Biology, 2006, 84, 3, 239
- 58, , , , , , Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia, Clinical & Experimental Immunology, 2006, 143, 2Direct Link:
- 59, , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 2005, 436, 7053, 946
- 60, Development of prophylactic and therapeutic vaccines against hepatitis C virus, Expert Review of Vaccines, 2005, 4, 3, 351
- 61
- 62, , , , , Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection, Clinical & Experimental Immunology, 2005, 142, 2Direct Link:
- 63
- 64, , , , , , , , , , , , , Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee, Hepatology, 2005, 42, 6Direct Link:
- 65, , , , T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005, 32, 2, 75
- 66
- 67, A critical role for the chimpanzee model in the study of hepatitis C, Hepatology, 2004, 39, 6Direct Link:
- 68, , , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004, 58, 1, 391
- 69, , , , Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004, 39, 4Direct Link:
- 70, , , , , , , , , , Effects of antiviral therapy on the cellular immune response in acute hepatitis C, Hepatology, 2004, 40, 1Direct Link:
- 71, , , , , , , Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees, Hepatology, 2004, 39, 6Direct Link:
- 72, , , , , , , , , Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections, Journal of Viral Hepatitis, 2004, 11, 3Direct Link:
- 73, , Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27–March 1, 2003, Hepatology, 2004, 39, 2Direct Link:
- 74, , , , Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection, Vaccine, 2004, 22, 8, 991
- 75, , , Recent developments in target identification against hepatitis C virus, Expert Opinion on Therapeutic Targets, 2004, 8, 4, 295
- 76, , , , , Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice, Vaccine, 2004, 22, 21-22, 2717
- 77, Reexamining the role of the humoral immune response in control of hepatitis C virus infection, Hepatology, 2004, 40, 3Direct Link:
- 78, , , Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?, Digestive and Liver Disease, 2004, 36, 11, 703
- 79, , , , , , , , Spontaneous clearance of hepatitis C virus after long-term opiate dependence therapy with buprenorphine, Journal of Viral Hepatitis, 2004, 11, 6Direct Link:
- 80, What is the nature of the problem?, Journal of Viral Hepatitis, 2004, 11,Direct Link:
- 81, , Chronic HCV infection and the clonality of intrahepatic T cells, Journal of Hepatology, 2003, 38, 5, 677
- 82, , , , , , , , , , DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus, Immunology Letters, 2003, 88, 1, 1
- 83, , , , , , , , , , , Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees, Virology, 2003, 314, 2, 601
- 84, , Hepatitis C virus infection: when silence is deception, Trends in Immunology, 2003, 24, 8, 456
- 85, , , , Neutralizing antibodies in hepatitis c virus infection: a review of immunological and clinical characteristics, Gastroenterology, 2003, 125, 2, 597
- 86, , , Of chimps and men–finding the path to an HCV vaccine, Hepatology, 2003, 37, 6Direct Link:
- 87
- 88, , , Bridge over troubled water: Protection against hepatitis C virus persistence?, Hepatology, 2002, 36, 6Direct Link:
- 89, , , , Hepatitis C flare due to superinfection by genotype 4 in an HCV genotype 1b chronic carrier, European Journal of Gastroenterology & Hepatology, 2002, 14, 8, 879
- 90, , , , , Hepatitis C: molecular virology and antiviral targets, Trends in Molecular Medicine, 2002, 8, 10, 476
- 91
- 92, , , , , , , , , Protection against persistence of hepatitis C, The Lancet, 2002, 359, 9316, 1478
- 93, Secondary persistent infection with hepatitis C virus: a challenge for adaptive immunity, The Lancet, 2002, 359, 9316, 1452
- 94, , , The challenge of developing a vaccine against hepatitis C virus, Journal of Hepatology, 2002, 37, 5, 684
- 95, , , Hepatitis C,Direct Link: